Log In
Print
BCIQ
Print
Print this Print this
 

orantinib (TSU-68)

  Manage Alerts
Collapse Summary General Information
Company Taiho Pharmaceutical Co. Ltd.
DescriptionOral small molecule inhibitor of multiple receptor tyrosine kinases
Molecular Target Vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) (VEGFR-2) ; Platelet derived growth factor receptor (PDGFR)
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today